Edison Pharma Sheds Light On Commercialization Plans Through Deal with Dainippon Sumitomo
This article was originally published in PharmAsia News
Executive Summary
The small Mountain View, Calif.-based biotech is preparing to commercialize its first product now that it has found financing from a partnership with Japan’s Dainippon Sumitomo.